Oric Pharmaceuticals (ORIC) Current Assets (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Current Assets came in at $290.2 million in Q1 2026, up 37.27% YoY from $211.4 million in Q1 2025, and up 0.61% on a QoQ basis from $288.5 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Current Assets (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Current Assets data on file, last reported at $290.2 million in Q1 2026.
- Quarterly Current Assets rose 37.27% year-over-year to $290.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $290.2 million (up 37.27% YoY) and the FY2025 annual result came in at $288.5 million, up 10.0% from the prior year.
- Current Assets climbed to $290.2 million in Q1 2026, from $288.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $324.1 million in Q1 2024 to a low of $193.2 million in Q1 2023.
- A 5-year average of $254.4 million and a median of $262.2 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets surged 67.78% — and 2025, when it plunged 34.76%.
- Tracing ORIC's Current Assets over 5 years: stood at $210.5 million in 2022, then advanced by 1.02% to $212.6 million in 2023, then climbed by 23.36% to $262.2 million in 2024, then gained by 10.0% to $288.5 million in 2025, then climbed by 0.61% to $290.2 million in 2026.
- The last three Current Assets figures came in at $290.2 million (Q1 2026), $288.5 million (Q4 2025), and $295.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 273.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 273.70 Mn |
| Mar 31, 2026 | 290.23 Mn |
| Dec 31, 2025 | 288.47 Mn |
| Sep 30, 2025 | 295.59 Mn |
| Jun 30, 2025 | 291.12 Mn |
| Mar 31, 2025 | 211.43 Mn |
| Dec 31, 2024 | 262.25 Mn |
| Sep 30, 2024 | 279.43 Mn |
| Jun 30, 2024 | 294.60 Mn |
| Mar 31, 2024 | 324.08 Mn |
| Dec 31, 2023 | 212.60 Mn |
| Sep 30, 2023 | 232.24 Mn |
| Jun 30, 2023 | 268.36 Mn |
| Mar 31, 2023 | 193.16 Mn |
| Dec 31, 2022 | 210.46 Mn |
| Sep 30, 2022 | 198.69 Mn |
| Jun 30, 2022 | 233.53 Mn |
| Mar 31, 2022 | 239.09 Mn |
| Dec 31, 2021 | 240.52 Mn |
| Sep 30, 2021 | 292.85 Mn |